75 related articles for article (PubMed ID: 20473854)
61. Immunosuppressive tumor microenvironment in cervical cancer patients.
Piersma SJ
Cancer Microenviron; 2011 Dec; 4(3):361-75. PubMed ID: 21626415
[TBL] [Abstract][Full Text] [Related]
62. Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.
Alpizar YA; Chain B; Collins MK; Greenwood J; Katz D; Stauss HJ; Mitchison NA
Cancer Immunol Immunother; 2011 Aug; 60(8):1127-35. PubMed ID: 21479639
[TBL] [Abstract][Full Text] [Related]
63. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
[TBL] [Abstract][Full Text] [Related]
64. Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.
Piersma SJ; Welters MJ; van der Hulst JM; Kloth JN; Kwappenberg KM; Trimbos BJ; Melief CJ; Hellebrekers BW; Fleuren GJ; Kenter GG; Offringa R; van der Burg SH
Int J Cancer; 2008 Feb; 122(3):486-94. PubMed ID: 17955486
[TBL] [Abstract][Full Text] [Related]
65. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
66. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
67. CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia.
Molling JW; de Gruijl TD; Glim J; Moreno M; Rozendaal L; Meijer CJ; van den Eertwegh AJ; Scheper RJ; von Blomberg ME; Bontkes HJ
Int J Cancer; 2007 Oct; 121(8):1749-55. PubMed ID: 17582606
[TBL] [Abstract][Full Text] [Related]
68. The detection of circulating human papillomavirus-specific T cells is associated with improved survival of patients with deeply infiltrating tumors.
Heusinkveld M; Welters MJ; van Poelgeest MI; van der Hulst JM; Melief CJ; Fleuren GJ; Kenter GG; van der Burg SH
Int J Cancer; 2011 Jan; 128(2):379-89. PubMed ID: 20473854
[TBL] [Abstract][Full Text] [Related]
69.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
70.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
71.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
72.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]